Glimepiride and Brain stem infarction - a phase IV clinical study of FDA data

Summary:

Brain stem infarction is reported as a side effect among people who take Glimepiride (glimepiride), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Amlodipine, and have High blood pressure.

The phase IV clinical study analyzes which people have Brain stem infarction when taking Glimepiride. It is created by eHealthMe based on reports of 45,086 people who have side effects when taking Glimepiride from the FDA, and is updated regularly.

What is Glimepiride?

Glimepiride has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 45,909 Glimepiride users. Check the latest studies of Glimepiride.

What is Brain stem infarction?

Brain stem infarction (brainstem stroke) is found to be associated with 192 drugs and 367 conditions by eHealthMe. Check the latest studies of Brain stem infarction.

On Jul, 14, 2026

45,086 people reported to have side effects when taking Glimepiride.
Among them, 12 people (0.03%) have Brain stem infarction.

Could Glimepiride cause Brain stem infarction?

Among these 12 people:

How long have people been on Glimepiride when they have Brain stem infarction? *

What is the gender of people who have Brain stem infarction when taking Glimepiride? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Brain stem infarction when taking Glimepiride? *

What are other drugs people take besides Glimepiride? *

What are other side effects people have besides Brain stem infarction? *

Cerebellar Infarction (impaired blood circulation to cerebellum): 2 people, 16.67%
Urination - Excessive Volume: 1 person, 8.33%
Thirst: 1 person, 8.33%
Blood Glucose Increased: 1 person, 8.33%
Dehydration (dryness resulting from the removal of water): 1 person, 8.33%
Dizziness: 1 person, 8.33%
Gait Disturbance: 1 person, 8.33%
Glycosylated Haemoglobin Increased: 1 person, 8.33%
Haematocrit Decreased: 1 person, 8.33%
Haemoglobin Decreased: 1 person, 8.33%

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 58.33%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 25.00%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 8.33%
Pneumonia: 1 person, 8.33%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Glimepiride and have Brain stem infarction?

- Check whether Brain stem infarction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glimepiride:

Glimepiride (45,909 reports)

Browse all side effects of Glimepiride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Brain stem infarction:

Brain stem infarction (192 drugs)

Browse all the conditions that are associated with Brain stem infarction:

Brain stem infarction (367 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glimepiride (the active ingredients of Glimepiride) and Glimepiride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.